Spear Dermatology Products, Inc. Introduces Refissa(TM) Tretinoin Cream USP (Emollient) 0.05%

RANDOLPH, N.J.--(BUSINESS WIRE)--Insert after sixth graph of release: Important Safety Information: Refissa 0.05% is a prescription medicine that may reduce fine facial wrinkles and mottled hyperpigmentation in patients who also protect their skin from the sun and wear sunscreen daily. Refissa does not eliminate wrinkles, repair sun damaged skin or reverse photo-aging. Avoid medicines that may increase your sensitivity to sunlight, ask your pharmacist. Do not use if you are pregnant, attempting pregnancy, or nursing. Refissa, early in treatment, may cause redness, itching, burning, stinging and peeling. Please see Full Prescribing Information at www.refissa.com.

MORE ON THIS TOPIC